Germanys Sign Science Pact

WEST BERLIN—West and East Germany have agreed to pursue more than two dozen scientific and technological projects as part of a joint agreement signed last week. The announcement was made on the occasion of the first visit to Bonn by East German General Secretary Erich Honecker The agreement comes after 34 rounds of negotiations in the 15 years since the two countries first established formal relationships. A panel of government officials and scientists from each country will be create

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WEST BERLIN—West and East Germany have agreed to pursue more than two dozen scientific and technological projects as part of a joint agreement signed last week.

The announcement was made on the occasion of the first visit to Bonn by East German General Secretary Erich Honecker The agreement comes after 34 rounds of negotiations in the 15 years since the two countries first established formal relationships.

A panel of government officials and scientists from each country will be created to coordinate the joint efforts. So far 27 projects have been selected, including work involving energy research and tech- nology, nuclear, physics and safety issues, materials science and production technology, biotechnology, environmental and agricultural research, AIDS and cancer research, coal liquefaction and fluidized bed combustion.

Although no money has been committed to the joint efforts, Heinz Riesenhuber, West German minister for research and technology, has stated repeatedly that no project will ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies